Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil
The symptoms of Alzheimer's disease (AD) do not include only memory loss and cognitive decline but also neuropsychiatric manifestation. These AD-related symptoms are usually treated with the aid of antipsychotics; however, their effects on cognition and safety remain unexplored. The present stu...
Saved in:
Main Authors: | Joanna Sikora (Author), Maria Podsiedlik (Author), Tadeusz Pietras (Author), Marcin Kosmalski (Author), Mikołaj Matłoka (Author), Rafał Moszczyński-Petkowski (Author), Maciej Wieczorek (Author), Magdalena Markowicz-Piasecka (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors
by: Ana I. Ahuja-Casarín, et al.
Published: (2021) -
Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
by: Magdalena Markowicz-Piasecka, et al.
Published: (2018) -
A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)
by: Tereza Cristina Santos Evangelista, et al.
Published: (2022) -
Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's Disease
by: Saurabh G. Londhe, et al.
Published: (2024) -
Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling
by: Bo Feng, et al.
Published: (2017)